Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005-2016

Hypertension

Volumn 75, Issue 4, 2020, Pages 973-981

  Derington, Catherine G ^a,b   King, Jordan B ^a,c   Herrick, Jennifer S ^c   Shimbo, Daichi ^d   Kronish, Ian M ^d   Saseen, Joseph J ^b,e   Muntner, Paul ^f   Moran, Andrew E ^d   Bress, Adam P ^c  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

antihypertensive agents; blood pressure; cardiovascular agents; cardiovascular diseases; hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; BLOOD PRESSURE; COMBINATION DRUG THERAPY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NUTRITION; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NUTRITION SURVEYS; UNITED STATES;

EID: 85081945841     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.119.14360     Document Type: Article

References (37)

1. Egan BM, Zhao Y, Axon RN, US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010 303 2043 2050. doi: 10.1001/jama.2010.650
2. Zhang Y, Moran AE, Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999 to 2014. Hypertension 2017 70 736 742. doi: 10.1161/HYPERTENSIONAHA.117.09801
3. Fryar CD, Ostchega Y, Hales CM, Zhang G, Kruszon-Moran D, Hypertension Prevalence and Control Among Adults in the United States, 2015-2016. 2017 Hyattsville, MD. Availabale at: https://www.cdc.gov/nchs/data/databriefs/db289.pdf. Accessed June 5, 2018
4. Cushman WC, Ford CE, Einhorn PT, Wright JT Jr, Preston RA, Davis BR, Basile JN, Whelton PK, Weiss RJ, Bastien A, ALLHAT Collaborative Research Group Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 2008 10 751 760. doi: 10.1111/j.1751-7176.2008.00015.x
5. The ACCORD Study Group Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010 362 1575 1585. doi:10.1056/NEJMoa1001286
6. Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015 373 2103 2116. doi:10.1056/NEJMoa1511939
7. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ, Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009 122 290 300. doi: 10.1016/j.amjmed.2008.09.038
8. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 2018 71 e127 e248. doi: 10.1016/j.jacc.2017.11.006
9. Williams B, Mancia G, Ten commandments of the 2018 ESC/ESH HTN guidelines on hypertension in adults. Eur Heart J 2018 39 3007 3008. doi: 10.1093/eurheartj/ehy439
10. Gradman AH, Basile JN, Carter BL, Bakris GL, American Society of Hypertension Writing Group Combination therapy in hypertension. J Clin Hypertens (Greenwich) 2011 13 146 154. doi: 10.1111/j.1751-7176.2010.00397.x
11. Gu Q, Paulose-Ram R, Dillon C, Burt V, Antihypertensive medication use among US adults with hypertension. Circulation 2006 113 213 221. doi: 10.1161/CIRCULATIONAHA.105.542290
12. Gu Q, Burt VL, Paulose-Ram R, Dillon CF, Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the national health and nutrition examination survey 1999-2004. Am J Hypertens 2008 21 789 798. doi:10.1038/ajh.2008.185
13. Gu Q, Burt VL, Dillon CF, Yoon S, Trends in antihypertensive medication use and blood pressure control among united states adults with hypertension: the national health and nutrition examination survey, 2001 to 2010. Circulation 2012 126 2105 2114. doi: 10.1161/CIRCULATIONAHA.112.096156
14. Shah SJ, Stafford RS, Current trends of hypertension treatment in the United States. Am J Hypertens 2017 30 1008 1014. doi: 10.1093/ajh/hpx085
15. Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S, Said AR, Nelapalli NK, Min Y, Tun KD, Jamallulail SI, A review on prescribing patterns of antihypertensive drugs. Clin Hypertens 2015 22 7. doi: 10.1186/s40885-016-0042-0
16. National Center for Health Statistics NHANES-National Health and Nutrition Examination Survey. Available at: https://www.cdc.gov/nchs/nhanes/index.htm. Accessed July 22, 2019
17. Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J, National health and nutrition examination survey: plan and operations, 1999-2010. Vital Heal Stat 2013 1 1 37
18. National Center for Health Statistics Specifying Weighting Parameters. Available at: https://www.cdc.gov/nchs/tutorials/nhanes/surveydesign/weighting/intro.htm. Published 2013. Accessed July 17, 2019
19. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med 2009 150 604 612. doi: 10.7326/0003-4819-150-9-200905050-00006
20. Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014 129 suppl 2 S49 S73. doi:10.1161/01.cir.0000437741.48606.98
21. Centers for Disease Control and Prevention and National Center for Health Statistics National Health and Nutrition Examination Survey Blood Pressure Questionnaire. 2015 Hyattsville, MD. Available at: https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/questionnaires/BPQ_I.pdf. Accessed February 15, 2019
22. Centers for Disease Control and Prevention and National Center for Health Statistics. National Health and Nutrition Examination Survey Dietary Supplements and Prescription Medication Questionnaire. 2015 Hyattsville, MD. Available at: https://wwwn.cdc.gov/nchs/data/nhanes/2015-2016/questionnaires/DSQ_I.pdf. Accessed February 15, 2019
23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003 289 2560 2572. doi: 10.1001/jama.289.19.2560
24. Salam A, Atkins ER, Hsu B, Webster R, Patel A, Rodgers A, Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. J Hypertens 2019 37 1567 1573. doi: 10.1097/HJH.0000000000002089
25. Williams B, Shaw A, Durrant R, Crinson I, Pagliari C, de Lusignan S, Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM 2005 98 885 893. doi: 10.1093/qjmed/hci139
26. Webster R, Salam A, de Silva HA, Selak V, Stepien S, Rajapakse S, Amarasekara S, Amarasena N, Billot L, de Silva AP, TRIUMPH Study Group Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial. JAMA 2018 320 566 579. doi: 10.1001/jama.2018.10359
27. Law MR, Wald NJ, Morris JK, Jordan RE, Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003 326 1427. doi: 10.1136/bmj.326.7404.1427
28. Mahmud A, Feely J, Low-dose quadruple antihypertensive combination: more efficacious than individual agents-a preliminary report. Hypertension 2007 49 272 275. doi: 10.1161/01.HYP.0000254479.66645.a3
29. Benjamin IJ, Kreutz R, Olsen MH, Schutte AE, Lopez-Jaramillo P, Frieden TR, Sliwa K, Lackland DT, Brainin M, Fixed-dose combination antihypertensive medications. Lancet 2019 394 637 638. doi: 10.1016/S0140-6736(19)31629-0
30. Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, INVEST Investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003 290 2805 2816. doi: 10.1001/jama.290.21.2805
31. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 359 995 1003. doi: 10.1016/S0140-6736(02)08089-3
32. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, ASCOT Investigators Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 366 895 906. doi: 10.1016/S0140-6736(05)67185-1
33. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014 311 507 520. doi: 10.1001/jama.2013.284427
34. Jamerson K, Weber MA, Bakris GL, Dahlöf B, Pitt B, Shi V, Hester A, Gupte J, Gatlin M, Velazquez EJ, ACCOMPLISH Trial Investigators Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008 359 2417 2428. doi: 10.1056/NEJMoa0806182
35. Frank J, Managing hypertension using combination therapy. Am Fam Physician 2008 77 1279 1286
36. Bian B, Kelton CML, Guo JJ, Wigle PR, ACE inhibitor and ARB utilization and expenditures in the medicaid fee-for-service program from 1991 to 2008. J Manag Care Pharm 2010 16 671 679. doi:10.18553/jmcp.2010.16.9.671
37. DiPette DJ, Skeete J, Ridley E, Campbell NRC, Lopez-Jaramillo P, Kishore SP, Jaffe MG, Coca A, Townsend RR, Ordunez P, Fixed-dose combination pharmacologic therapy to improve hypertension control worldwide: Clinical perspective and policy implications. J Clin Hypertens 2019 21 4 15. doi:10.1111/jch.13426